Is Low Blood Pressure Genetic?

Blood pressure has a strong genetic component, with twin studies consistently showing that roughly half of the variation between people traces back to inherited factors. That does not mean there is a single “low blood pressure gene.” Instead, your blood pressure reflects the combined pull of hundreds or thousands of small genetic effects, layered on top of diet, activity level, stress, and other environmental influences. For most people with naturally low readings, genetics set the stage, but rare single-gene disorders can also drive blood pressure dramatically downward.

How Much of Blood Pressure Is Heritable

The clearest evidence for a genetic contribution to blood pressure comes from twin studies, which compare identical twins (who share all their DNA) with fraternal twins (who share about half). A large study of Chinese adult twins found that genetic factors accounted for about 54% of the variation in systolic blood pressure and about 50% of the variation in diastolic blood pressure, with the remaining variation explained by individual environmental exposures rather than shared family environment.¹ Other reviews have placed the genetic contribution somewhere between 30% and 50%.²

Those numbers apply to blood pressure in general, not specifically to low blood pressure. But the logic runs in both directions: if your genetic makeup pushes toward the lower end of the distribution, you are more likely to have readings that other people would consider low. Family members who share those gene variants tend to cluster together at the lower end as well. If your parents and siblings have always run on the low side, the odds are good that some of that tendency was passed down rather than coincidental.

Thousands of Small Genetic Effects Add Up

For the vast majority of people, blood pressure is not controlled by one or two powerful genes. It is what geneticists call a polygenic trait, shaped by a very large number of DNA variants, each nudging the reading up or down by a tiny amount. The largest single-stage genome-wide study of blood pressure to date, covering over a million people of European ancestry, identified more than 2,100 independent genetic signals associated with blood pressure and 113 previously unknown gene regions.³ Together, those signals explained more than 60% of the heritable portion of blood pressure variation. People in the top 10% of genetic risk scored, on average, about 17 mmHg higher in systolic blood pressure than people in the bottom 10%, and had roughly seven times the odds of developing hypertension.⁴

The flip side of that finding is just as important: people who fall in the bottom decile of genetic risk carry a constellation of variants that collectively keep their blood pressure lower. They are not “missing” something; their genetic hand simply tilts the balance away from the mechanisms that raise pressure. Studies in African-ancestry populations have identified some of the same gene regions, along with additional ones, suggesting that the basic polygenic architecture is shared across ethnic groups even though the specific variants and their frequencies differ.⁵

Nitric Oxide and Vascular Relaxation

One concrete way genetics can keep blood pressure low involves nitric oxide, a molecule that tells blood vessel walls to relax. People who carry certain common variants in the NOS3 gene (which encodes the enzyme that produces nitric oxide) and the GUCY1A3 gene (which helps relay the relaxation signal inside cells) tend to have higher expression of those genes. When researchers combined the two variants into a genetic score standardized to a 5 mmHg reduction in mean arterial pressure, carriers showed the downstream effects you would expect from chronically more relaxed arteries.⁶ This is one of the clearer mechanistic paths from a genetic variant to a measurably lower blood pressure, and it illustrates how even common gene variants, carried by a large fraction of the population, can push readings downward.

Rare Single-Gene Disorders That Cause Very Low Blood Pressure

While most low blood pressure is polygenic, a handful of rare inherited conditions can cause dangerously low readings. These are worth knowing about because their presentations are distinctive and, in some cases, treatable.

Dopamine beta-hydroxylase (DBH) deficiency is an extremely rare autosomal recessive disorder in which the body cannot convert dopamine into norepinephrine or epinephrine. Without those two hormones, the cardiovascular system loses a critical tool for maintaining pressure when you stand up or exert yourself. Newborns with DBH deficiency may have episodes of low body temperature, low blood sugar, and low blood pressure, and survivors often develop overwhelming orthostatic hypotension by late childhood that severely limits daily activities.⁷ In severe cases, the drops in pressure can trigger seizures.⁸ A synthetic amino acid precursor called L-DOPS can bypass the missing enzyme and restore some norepinephrine production, making life manageable for many patients.⁹

On the kidney side, Bartter syndrome involves mutations in genes that control how the kidneys handle salt. The result is excessive salt wasting, which pulls down blood volume and blood pressure. One form of Bartter syndrome, caused by variants in the KCNJ1 gene, has been singled out in population studies because common milder variants in the same gene also associate with lower blood pressure in the general population.¹⁰ That is a recurring pattern in blood pressure genetics: a rare mutation causes a dramatic syndrome, and common, less potent variants in the same gene create subtle shifts that blend into the normal range.

Genetics of Fainting and Vasovagal Syncope

If you have ever fainted or come close to it when standing still for a long time, giving blood, or seeing something unpleasant, you have experienced a rapid, temporary plunge in blood pressure and heart rate known as vasovagal syncope. It tends to run in families, and twin studies, genome-wide scans, and family-based studies all point to a heritable component, though the specific genes responsible are still being mapped out.¹¹

One detailed study of families with multiple generations of fainters identified a surprising sex-dependent pattern involving serotonin signaling genes. In males, certain variants in the HTR1A serotonin receptor gene were strongly linked to syncope: men with one genotype had about a 9% chance of fainting episodes, while men with the opposite genotype had a 77% chance. But the same genetic variants did not predict fainting in women. Other serotonin-related variants showed opposite effects depending on sex, increasing syncope risk in one sex while decreasing it in the other.¹² This is a good reminder that genetic effects on blood pressure regulation are not always simple or uniform, and that sex hormones likely modulate how gene variants play out.

Orthostatic Hypotension and Neurodegenerative Disease

Orthostatic hypotension, the kind of blood pressure drop that hits when you stand up, is partly a problem of aging blood vessels and stiffening reflexes. But it also has a genetic dimension, especially in the context of neurological conditions. In Parkinson’s disease, the autonomic nerves that help maintain blood pressure upon standing can degenerate along with the movement-controlling circuits in the brain. A cross-sectional genetic study found that the genetic variants linked to this form of blood pressure instability in Parkinson’s patients suggested a broader genetic influence than previously appreciated, even after ruling out confounders like age, sex, and medications.¹³

There is also a specific genetic subtype of Parkinson’s that makes this problem worse. Patients carrying variants in the GBA gene (which also causes Gaucher disease when two copies are affected) experience more pronounced drops in systolic blood pressure when moving from lying down to standing up compared to Parkinson’s patients without GBA variants. They also report orthostatic symptoms more frequently.¹⁴ For families dealing with Parkinson’s, knowing whether a GBA variant is present can help anticipate and manage this particular complication.

Is Genetically Low Blood Pressure Actually Good for You

For most cardiovascular outcomes, the answer is a clear yes. A large Mendelian randomization study using UK Biobank data found a consistent, linear relationship between genetically predicted blood pressure and cardiovascular disease: each 10 mmHg increase in genetically predicted systolic blood pressure was associated with about a 32% increase in the odds of total cardiovascular disease, a 33% increase in ischemic heart disease, and a 35% increase in stroke. There was no evidence of a threshold below which lower pressure stopped being protective.¹⁵ A related analysis estimated that a population-wide 5 mmHg reduction in systolic blood pressure would reduce cardiovascular morbidity by about 17%, and a 10 mmHg reduction by about 31%.¹⁶

But the picture is not entirely rosy at the lower end. A study using polygenic risk scores in a UK Biobank sample found that genetic propensity for low systolic and diastolic blood pressure was associated with slower reaction times, a measure of attention function. In other words, people whose genes pushed their blood pressure toward the low end showed somewhat worse performance on cognitive tasks that require quick responses.¹⁷ The likely explanation involves brain perfusion: when blood pressure is chronically on the low side, the brain may not get quite as robust a supply of oxygen-rich blood, especially during demanding tasks. This does not mean low blood pressure causes dementia, but it suggests the cardiovascular benefits come with a mild cognitive trade-off that researchers are still working to quantify.

How Diet and Lifestyle Interact With Blood Pressure Genes

Having a genetic predisposition toward lower blood pressure does not lock you into a fixed reading. Gene-environment interactions are real, and diet is one of the most studied. In a study of normotensive adults, researchers looked at how variants in genes involved in the renin-angiotensin system interacted with dietary sodium, potassium, calcium, and magnesium. They found that people carrying the G allele of a variant in the AGT gene had higher systolic blood pressure as their sodium and magnesium intake went up, compared to people with a different version of the gene who did not respond the same way.¹⁸ This means that two people eating the same salty meal can experience different blood pressure responses depending on their genetic background.

The practical implication is that standard lifestyle advice, like reducing sodium intake and eating more potassium-rich foods, is generally sound, but some people will benefit more than others. If you naturally run low, a high-sodium diet is less likely to push you into unhealthy territory than it would someone whose genes tilt the other way. But the interaction is not a free pass: the same genetic sensitivity to dietary minerals works in both directions, and the effect accumulates over years.

The Gut Microbiome Connection

An emerging line of research connects the bacteria in your gut to blood pressure regulation through short-chain fatty acids, the compounds gut bacteria produce when they ferment dietary fiber. A study of multiple ethnic groups found clear differences in the levels of these fatty acids between people with high and low blood pressure, with several types of bacteria linked to their production. Short-chain fatty acids like propionate and butyrate can dilate arteries by activating certain receptors on blood vessel walls and in the kidneys. But the body also has a counterbalancing receptor that responds to the same compounds by triggering renin release, which raises blood pressure.¹⁹ The net effect on your blood pressure likely depends on which receptors dominate in your particular body, which may itself be partly genetically determined.

This is still early-stage research, and nobody should be taking probiotic supplements specifically to lower blood pressure based on current evidence. But the finding is interesting because it hints at yet another layer of biological variability, mediated by the interplay between your genes, your diet, and the trillions of microbes living in your intestines, that contributes to where your blood pressure settles.

Why Your Genes Affect How You Respond to Blood Pressure Medications

If you take medication for blood pressure, you have probably noticed that finding the right drug and dose can be a process of trial and error. Part of the reason is genetic. The same variants that influence your baseline blood pressure also affect how your body processes and responds to different drug classes.²⁰ A genome-wide pharmacogenomic study tested four classes of blood pressure medications in the same patients and found suggestive associations between specific gene variants and how well individual drugs worked. For example, a variant in the NPHS1 gene appeared to influence the response to an angiotensin receptor blocker, while different variants near the ALDH1A3 and CLIC5 genes were linked to responsiveness to a common diuretic.²¹

These findings are not yet mature enough to guide prescribing in most clinics. But the direction is clear: in the future, genetic profiles could help doctors skip the trial-and-error phase by predicting which drug class a patient is most likely to respond to, and which ones might drop their blood pressure too far. For people who already run low, this is especially relevant. A medication that works perfectly for a patient with borderline hypertension could push someone with genetically low pressure into symptomatic territory.

Epigenetic Programming Before Birth

Your blood pressure genetics are not entirely fixed at conception. Conditions in the womb can modify how blood pressure-related genes are expressed for the rest of your life through a process called epigenetic programming. Animal research has shown that when a mother’s diet is severely protein-restricted during pregnancy, her offspring develop lasting changes in the expression of genes in the renin-angiotensin system, one of the body’s main blood pressure control circuits, through alterations in DNA methylation patterns.²² In these studies, the changes pushed adult offspring toward higher blood pressure, but the principle works both ways: the prenatal environment can dial blood pressure-related gene activity up or down in ways that persist into adulthood.

This means that when you ask whether low blood pressure is genetic, the answer includes not just the DNA sequence you inherited but also the chemical tags placed on that DNA by the environment you experienced before birth. Two people with identical blood pressure gene variants could have meaningfully different readings because of differences in prenatal nutrition, stress exposure, or other conditions during fetal development. It adds one more reason why family patterns in blood pressure are never perfectly predictable from DNA alone.

Evolutionary Origins of Blood Pressure Variation

Some of the genetic variation in blood pressure that exists today reflects adaptations to environments that no longer match how most people live. A review examining the evolutionary history of blood pressure-related genes found that ancestral variants in systems governing sodium appetite and retention, which were advantageous when salt was scarce and physical activity was constant, can become maladaptive in modern environments where salt is abundant and exercise is optional.²³ Populations that historically lived in environments with plentiful salt, or that adopted agriculture and its salt-rich diets earlier, may have experienced less selection pressure to retain sodium and could carry gene variants that lean toward lower blood pressure. This evolutionary lens helps explain why blood pressure distributions vary across human populations in ways that do not reduce to simple dietary or lifestyle differences. Some of the genetic architecture underlying low blood pressure is not random noise; it is the residue of selection pressures that played out over thousands of generations.